In particular, IL-6, soluble IL-6 receptor, soluble IL-2 receptor alpha, interferon gamma (IFN-γ), and granulocyte-macrophage colony-stimulating factor (GMCSF) increase in patients with severe CRS [22]. This evidence concerns the gene IL6 and congenital rubella syndrome.